Literature DB >> 8617959

Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.

M Pope1, S W Chung, T Mosmann, J L Leibowitz, R M Gorczynski, G A Levy.   

Abstract

Murine hepatitis virus strain 3 (MHV-3) produces a strain-dependent spectrum of disease. The development of liver necrosis has been shown to be related to production of a unique macrophage procoagulant activity (PCA), encoded by the gene fgl-2, in susceptible mice. These studies were designed to examine the influence of Th1/Th2 cells on resistance/susceptibility and production of macrophage PCA in resistant (A/J) and susceptible (BALB/cJ) strains of mice following infection with MHV-3. Immunization of A/J mice with MHV-3 induced a Th1 cellular immune response, and one Th1 cell line (3E9.1) protected susceptible mice and inhibited PCA production by macrophages both in vitro and in vivo. In contrast, immunization of BALB/cJ mice with an attenuated variant of MHV-3 derived from passaging MHV-3 in YAC-1 cells resulted in a Th2 response. Transfer of spleen cells and T cell lines from immunized BALB/cJ mice failed to protect naive susceptible syngeneic mice from infection with MHV-3 and augmented macrophage PCA production to MHV-3 in vitro. However, serum from immunized BALB/cJ mice contained high titrated neutralizing Ab that protected naive BALB/cJ animals from lethal primary MHV-3 infection. These results demonstrate that susceptible BALB/cJ mice generate a Th2 response following MHV-3 infection and that these Th2 cells neither inhibit MHV-3-induced macrophage PCA production nor protect naive mice from MHV-3 infection. The results suggest that Ab protects against primary infection but cannot eradicate ongoing infection. Thus, these data define the differential role of Th1/Th2 lymphocytes in primary and secondary MHV-3 infection and emphasize the importance of PCA in the pathogenesis of MHV-3 infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617959

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response.

Authors:  P J Lewis; L A Babiuk
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice.

Authors:  Nadine De Albuquerque; Ehtesham Baig; Xuezhong Ma; Jianhua Zhang; William He; Andrea Rowe; Marlena Habal; Mingfeng Liu; Itay Shalev; Gregory P Downey; Reginald Gorczynski; Jagdish Butany; Julian Leibowitz; Susan R Weiss; Ian D McGilvray; M James Phillips; Eleanor N Fish; Gary A Levy
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

3.  Proteasome inhibition in vivo promotes survival in a lethal murine model of severe acute respiratory syndrome.

Authors:  Xue-Zhong Ma; Agata Bartczak; Jianhua Zhang; Ramzi Khattar; Limin Chen; Ming Feng Liu; Aled Edwards; Gary Levy; Ian D McGilvray
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

4.  Comparative evaluation of two hemagglutinating encephalomyelitis coronavirus vaccine candidates in mice.

Authors:  Keyan Chen; Kui Zhao; Wenqi He; Wei Gao; Chuanbo Zhao; Li Wang; Wei Pan; Deguang Song; Chengli Wang; Feng Gao
Journal:  Clin Vaccine Immunol       Date:  2012-04-18

5.  Senescent BALB/c mice are able to develop resistance to Leishmania major infection.

Authors:  Jan Ehrchen; Anca Sindrilaru; Stephan Grabbe; Frank Schönlau; Christian Schlesiger; Clemens Sorg; Karin Scharffetter-Kochanek; Cord Sunderkötter
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

6.  Mouse hepatitis viral infection induces an extrathymic differentiation of the specific intrahepatic alpha beta-TCRintermediate LFA-1high T-cell population.

Authors:  L Lamontagne; E Massicotte; C Page
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

Review 7.  T cell-mediated immune response to respiratory coronaviruses.

Authors:  Rudragouda Channappanavar; Jincun Zhao; Stanley Perlman
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

8.  Telbivudine preserves T-helper 1 cytokine production and downregulates programmed death ligand 1 in a mouse model of viral hepatitis.

Authors:  Z G Wu; W M Yan; W Guo; T Chen; Y Zou; H W Wang; X J Wang; X J Yang; Y L Lu; X P Luo; Q Ning
Journal:  J Viral Hepat       Date:  2010-03       Impact factor: 3.728

Review 9.  Severe acute respiratory syndrome and the liver.

Authors:  Atul Humar; Ian McGilvray; Murray J Phillips; Gary A Levy
Journal:  Hepatology       Date:  2004-02       Impact factor: 17.425

10.  A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.

Authors:  Naomi Takasuka; Hideki Fujii; Yoshimasa Takahashi; Masataka Kasai; Shigeru Morikawa; Shigeyuki Itamura; Koji Ishii; Masahiro Sakaguchi; Kazuo Ohnishi; Masamichi Ohshima; Shu-ichi Hashimoto; Takato Odagiri; Masato Tashiro; Hiroshi Yoshikura; Toshitada Takemori; Yasuko Tsunetsugu-Yokota
Journal:  Int Immunol       Date:  2004-08-16       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.